Coriell Institute for Medical Research and the NIH will make available new lines of induced pluripotent stem cells through the National Institutes of General Medical Sciences' Human Genetic Cell Repository at Coriell in Camden, N.J. The stem cells were derived from skin or blood cells of patients with Huntington's disease, juvenile onset diabetes or muscular dystrophy, among other diseases.

Related Summaries